Frontiers in Pharmacology (May 2016)

E2F4 promotes neuronal regeneration and functional recovery after spinal cord injury in zebrafish

  • Yuhei eNishimura,
  • Shota eSasagawa,
  • Yuka eHayakawa,
  • Soichiro eMurakami,
  • Yoshifumi eAshikawa,
  • Mizuki eYuge,
  • Shiko eOkabe,
  • Koki eKawaguchi,
  • Reiko eKawase,
  • TOSHIO eTANAKA

DOI
https://doi.org/10.3389/fphar.2016.00119
Journal volume & issue
Vol. 7

Abstract

Read online

Mammals exhibit poor recovery after spinal cord injury (SCI), whereas non-mammalian vertebrates exhibit significant spontaneous recovery after SCI. The mechanisms underlying this difference have not been fully elucidated; therefore, the purpose of this study was to investigate these mechanisms. Using comparative transcriptome analysis, we demonstrated that genes related to cell cycle were significantly enriched in the genes specifically dysregulated in zebrafish SCI. Most of the cell cycle-related genes dysregulated in zebrafish SCI were down-regulated, possibly through activation of e2f4. Using a larval zebrafish model of SCI, we demonstrated that the recovery of locomotive function and neuronal regeneration after SCI were significantly inhibited in zebrafish treated with an E2F4 inhibitor. These results suggest that activation of e2f4 after SCI may be responsible, at least in part, for the significant recovery in zebrafish. This provides novel insight into the lack of recovery after SCI in mammals and informs potential therapeutic strategies.

Keywords